Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

TransCanada (TRO): Gas is a 'screaming buy'


Bookmark and Share

 "Our focus this summer remains on building positions in the bombed-out natural gas market; there’s no other commodity this depressed, this unwanted and trading at such distressed levels," says Eric Roseman.

In his industry-leading, The Commodity Trend Alert, the resource expert explains, "Indeed, the bombed-out natural gas sector is screaming 'buy'." Here, he looks at TransCanada Corp. (NYSE: TRP).

"The way prices have been heading over the last several months you’d think the world doesn’t use this clean-burning fossil fuel anymore.

Advertisement
Banner

"Natural gas prices remain 70% off their 52-week high and more than 75% below their all-time highs almost four years ago when Hurricane Katrina smashed the Gulf of Mexico.

"And historically, the oil-to-gas ratio signals a major buy signal for natural gas with the spread or difference between crude oil to gas at 17.5. That’s a huge spread.

"Our newest portfolio position in this sector is North America’s largest natural gas pipeline operator – TransCanada. Based in Calgary, Alberta, TransCanada owns 36,500 miles of natural gas pipelines – most of which transport gas from Alberta to the eastern United States and Canada. 

"Roughly 50% of all the natural gas produced in western Canada is brought to market vis-à-vis TransCanada pipeline. The company also generates a significant chunk of its revenues from wholesale power generation.

"Basically, this is one big company that is a powerhouse in Alberta. If you’re moving natural gas through a pipeline up there, then the odds are pretty good you’ll use TRP.

"What I like about TRP is that the pipeline business is stable and dependable. Gross margins and operating income have consistently improved this decade and the dividend has grown by more than 25% over the last ten years.

"The company is also nearing the completion of its first phase of the Keystone pipeline – a $12 billion dollar project that will eventually carry 1.1 million barrels of oil sands crude a day from Alberta to refineries in the U.S. Midwest and Gulf Coast.

""In a tough global economy TransCanada Corp. serves as a blue-chip stock TransCanada Corp. currently trades 31% off its 52-week high of $39.31 and 37% below its all-time high last fall before the September-October global crash.

"The stock trades at 13.9 times trailing earnings, pays a fat 4.9% dividend in Canadian dollars and will rally sharply once depressed natural gas prices get off the ground. This is a great stock for all investors."


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary